Elissa Meites, MD, in her paper “Use of a 2-Dose Schedule for Human Papillomavirus Vaccination—Updated Recommendations of the Advisory Committee on Immunization Practices” (2016) justifies that HPV vaccinations should be administered starting at the age of 9 years of age by use of a 2-dose and 3-dose schedule. Meites provides evidence that immunogenicity was found to be noninferior with 2 doses in 9-year-old participants than 16 through 26-year-old participants administered with 3 doses. The purpose of her work is to prove thatHPV vaccines are highly effective and safe, a useful preventative tool and is necessary for it be introduced early to help prevent the spread of HPV infections and cancers associated with it. Meites establishes a relationship with healthcare providers who can help administer these recommended 2-dose or 3-dose schedules in children.
